Conclusion: Evaluation of hs-C-reactive protein on admission in STEMI patients undergoing primary PCI allows reliable risk stratification of these patients.

• 结论：接受直接PCI的STEMI患者入院时检测超敏C反应蛋白水平能够为区分高危患者提供证据。